Leon E. Chen

Director/Board Member at Eikon Therapeutics, Inc.

49 year

Health Technology

Finance

Consumer Services

Profile

Leon E.
Chen is the founder of KAI Pharmaceuticals, Inc. (founded in 2002).
He currently holds positions as a Director at Eikon Therapeutics, Inc., Remix Therapeutics, Inc., Velia, Inc., Logic Bio, and Partner at The Column Group LLC (since 2019).
Previously, he held positions as a Director at Crescendo Bioscience LLC, Sutro Biopharma, Inc., Genocea Biosciences, Inc., Nurix Therapeutics, Inc., LogicBio Therapeutics, Inc., Pionyr Immunotherapeutics, Inc., Principal at Venrock Associates, Partner at Skyline Management LLC, Venture Partner at OrbiMed Advisors Private Equity, and Chief Executive & Financial Officer at ESCAPE Bio, Inc. Dr. Chen obtained a doctorate degree from Stanford University in 2001, an undergraduate degree from the University of California, Berkeley in 1997, and an MBA from Stanford Graduate School of Business in 2009.

Leon E. Chen active positions

Companies	Position	Start
The Column Group LLC The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco.	Private Equity Investor	01/10/2019
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA.	Director/Board Member	-
Eikon Therapeutics, Inc. Eikon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Eikon Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Hayward, CA.	Director/Board Member	-
Velia, Inc. Velia, Inc. Packaged SoftwareTechnology Services Velia, Inc. is a company based in San Francisco, CA that is focused on harnessing the therapeutic potential of a novel class of human peptides. These peptides regulate biological functions that are vital to human health. The company was founded by Alan Saghatelian, Jonathan Weissman, Eric Olson, and Richard Scheller. John G. McHutchison has been the CEO of the company since 2023.	Director/Board Member	-

All active positions of Leon E. Chen

Former positions of Leon E. Chen

Companies	Position	End
LOGICBIO THERAPEUTICS, INC.	Director/Board Member	16/11/2022
NURIX THERAPEUTICS, INC.	Director/Board Member	28/05/2021
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.	Private Equity Investor	30/09/2019
ESCAPE Bio, Inc. ESCAPE Bio, Inc. BiotechnologyHealth Technology ESCAPE Bio, Inc. is a preclinical stage biopharmaceutical company. It focuses on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. The company was founded by Robert Mahley and Yadong Huang in 2015 and is headquartered in San Francisco, CA.	Chief Executive Officer	23/08/2018
Skyline Management LLC Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California.	Private Equity Investor	30/06/2013

See the detail of Leon E. Chen's experience

Training of Leon E. Chen

Stanford University	Doctorate Degree
University of California, Berkeley	Undergraduate Degree
Stanford Graduate School of Business	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Leon E. Chen's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
SUTRO BIOPHARMA, INC.	Health Technology
GENOCEA BIOSCIENCES, INC.	Health Technology
NURIX THERAPEUTICS, INC.	Health Technology

Private companies	12
Venrock Associates Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto.	Finance
KAI Pharmaceuticals, Inc. KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA.	Health Technology
Crescendo Bioscience LLC Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.	Commercial Services
Skyline Management LLC Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California.	Finance
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.	Finance
The Column Group LLC The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco.	Finance
LogicBio Therapeutics, Inc. LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA.	Health Technology
Pionyr Immunotherapeutics, Inc. Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA.	Health Technology
ESCAPE Bio, Inc. ESCAPE Bio, Inc. BiotechnologyHealth Technology ESCAPE Bio, Inc. is a preclinical stage biopharmaceutical company. It focuses on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. The company was founded by Robert Mahley and Yadong Huang in 2015 and is headquartered in San Francisco, CA.	Health Technology
Eikon Therapeutics, Inc. Eikon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Eikon Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Hayward, CA.	Commercial Services
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA.	Health Technology
Velia, Inc. Velia, Inc. Packaged SoftwareTechnology Services Velia, Inc. is a company based in San Francisco, CA that is focused on harnessing the therapeutic potential of a novel class of human peptides. These peptides regulate biological functions that are vital to human health. The company was founded by Alan Saghatelian, Jonathan Weissman, Eric Olson, and Richard Scheller. John G. McHutchison has been the CEO of the company since 2023.	Technology Services